The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

Intra-ImmuSG seeks to develop a safer and more effective cancer therapy via a combination of a targeted therapy and immunotherapy.

Burjeel Cancer Institute (BCI) has expanded its reach by opening a new centre at Burjeel Hospital Al Ain. This strategic ...

The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is ...

The American Association for Cancer Research Annual Meeting 2025 will be held from April 25-30 in Chicago, Illinois, providing a ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

A device developed by the Institute of Bioengineering of Catalonia and the Research Institute of Hospital del Mar allows replicating tumors and their environment to analyze the response to therapies.

Next-generation sequencing, proteomics analysis, and circulating tumor DNA demonstrate how precision medicine advances ...

The new center reflects Burjeel’s ongoing commitment to expanding its services and meeting the growing healthcare needs of ...